Newsroom | 11231 results

IRVINE, Calif.--(BUSINESS WIRE)--ReShape Lifesciences® (Nasdaq: RSLS) announced today that its shareholders have approved all of the proposals necessary to complete the previously announced merger with Vyome Therapeutics, which is expected to be effective for the commencement of trading on Friday, August 15, 2025. The shares of common stock of the combined company are expected to commence trading on The Nasdaq Capital Market under the name Vyome Holdings, Inc. and the trading symbol "HIND." “Vy...

PLANO, Texas--(BUSINESS WIRE)--QinFlow has launched its newest advanced fluid and blood warming solution to meet a critical need in hospital ORs and ICUs....

WAALRE, Netherlands--(BUSINESS WIRE)--VIVOLTA has partnered with Fibrothelium to manufacture SimplySilk® membrane, a silk membrane which supports guided bone regeneration in oral surgery....

MINNEAPOLIS--(BUSINESS WIRE)--HistoSonics, l’impresa che ha creato il sistema di istotripsia Edison® e l’innovativa piattaforma per la terapia con questa tecnica, oggi ha annunciato l’acquisizione della partecipazione di maggioranza guidata dal management da parte di un consorzio di investitori pubblici e privati rinomati globalmente – K5 Global, Bezos Expeditions e Wellington Management nonché altri investitori preesistenti e nuovi. L’operazione assegna a HistoSonics un valore di circa 2,25 mi...

MINNEAPOLIS--(BUSINESS WIRE)--HistoSonics Announces $2.25B Acquisition by Consortium of Top-Tier Investors...

MINNEAPOLIS--(BUSINESS WIRE)--HistoSonics, Entwickler des Edison® Histotripsy-Systems und einer neuartigen Histotripsy-Therapieplattform, gab heute bekannt, dass eine Gruppe weltweit anerkannter privater und öffentlicher Investoren, darunter K5 Global, Bezos Expeditions, Wellington Management sowie weitere neue und bestehende Investoren, unter Führung des Managements eine Mehrheitsbeteiligung erworben hat. Die Transaktion bewertet HistoSonics mit rund 2,25 Mrd. USD und versetzt das Unternehmen...

MINNEAPOLIS--(BUSINESS WIRE)--HistoSonics, de ontwikkelaar van het Edison® histotripsy-systeem en een nieuw histotripsy-behandelplatform, heeft vandaag bekendgemaakt dat een consortium van wereldwijd erkende particuliere en publieke investeerders, waaronder K5 Global, Bezos Expeditions, Wellington Management en andere nieuwe en bestaande investeerders, een meerderheidsbelang in het bedrijf heeft verworven. Met de transactie die HistoSonics op ongeveer 2,25 miljard dollar waardeert, kan het bedr...

MINNEÁPOLIS--(BUSINESS WIRE)--HistoSonics, desarrollador del sistema de histotricia Edison® y de la novedosa plataforma de terapia de histotricia, ha anunciado hoy la adquisición de una participación mayoritaria liderada por la dirección de un sindicato de inversores privados y públicos reconocidos en todo el mundo, incluyendo K5 Global, Bezos Expeditions, Wellington Management y otros inversores nuevos y existentes. La transacción otorga a HistoSonics un valor aproximado de 2250 millones de dó...

NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced financial results for the second quarter ended June 30, 2025. Second Quarter Highlights and Outlook (Unaudited) Second quarter worldwide revenue of $51.3 million, an increase of 16.3% from the year ago period. Revenue included $10.3 million of Motiva sales in the Un...

MINNEAPOLIS--(BUSINESS WIRE)--HistoSonics, développeur de l’Edison® Histotripsy System et d’une nouvelle plateforme de thérapie histotripsique, a annoncé aujourd’hui l’acquisition d’une participation majoritaire par un consortium d’investisseurs privés et publics de renommée mondiale, dont K5 Global, Bezos Expeditions, Wellington Management et d’autres investisseurs nouveaux et existants. Cette transaction valorise HistoSonics à environ 2,25 milliards de dollars et positionne l’entreprise pour...